SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
Xiaoxin X. Wang(Georgetown University), Moshe Levi(Georgetown University), Almut Grenz(University of Colorado Anschutz Medical Campus), Jeffrey B. Kopp(Kidney Care UK), Jonathan Levi(National Institutes of Health), Yuhuan Luo(University of Colorado Anschutz Medical Campus), Evgenia Dobrinskikh(Inserm), Michal Herman‐Edelstein(Rabin Medical Center), Hermann Koepsell(Goethe University Frankfurt), Yingqiong Peng(University of Colorado Anschutz Medical Campus), Dong Wang(University of Colorado Anschutz Medical Campus), Scott Lucia(University of Colorado Anschutz Medical Campus), Liru Qiu(University of Colorado Anschutz Medical Campus), Komuraiah Myakala(University of Colorado Anschutz Medical Campus), Vivette D. D’Agati(Columbia University), Avi Z. Rosenberg
Cited by 302
Related Papers
APOL1 Genetic Variants in Focal Segmental Glomerulosclerosis and HIV-Associated Nephropathy
|Journal of the American Society of Nephrology|2011|856
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis
|Nature Genetics|2008|706
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
|Journal of Lipid Research|2013|627
Glucose transporters in brain in health and disease
|Pflügers Archiv - European Journal of Physiology|2020|520
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501